about
Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.An overview of antiretroviral agents for treating HIV infection in paediatric populationComputational Approaches in Antibody-drug Conjugate Optimization for Targeted Cancer TherapyNewly Synthesized Oxygenated Xanthones as Potential P-Glycoprotein Activators: , , and StudiesProgress in Difluoroalkylation of Organic Substrates by Visible Light Photoredox CatalysisNew inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastomaLate-Stage 18 F-Difluoromethyl Labeling of N-Heteroaromatics with High Molar Activity for PET ImagingSynthesis, Biological Evaluation, and In Silico Studies of Novel Aminated Xanthones as Potential p53-Activating Agents
P50
Q38865504-B39BF2C1-3AF3-4C15-827D-D637A01722AAQ52665081-B6CB3A01-966C-402C-9841-6A8244336C27Q59353280-F59A5CA1-3C2C-457B-A552-B15A195EBD28Q62849288-4E6F2F07-DD68-4B4D-A9A0-51095F165141Q64255413-461D498C-8811-4157-89BA-5BE29F98783FQ91080952-1FC45FF7-4716-4EFF-9BFB-D3A31529EA8CQ91143940-16D36DA4-6695-47B1-B059-ED34F5212356Q92022504-F8590CB0-4416-4FFF-9385-A60C3E1F40B2Q92247319-354BB116-6B27-46E1-A935-8327AFC7678A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Agostinho Lemos
@ast
Agostinho Lemos
@en
Agostinho Lemos
@es
Agostinho Lemos
@nl
type
label
Agostinho Lemos
@ast
Agostinho Lemos
@en
Agostinho Lemos
@es
Agostinho Lemos
@nl
prefLabel
Agostinho Lemos
@ast
Agostinho Lemos
@en
Agostinho Lemos
@es
Agostinho Lemos
@nl
P1053
J-3966-2016
P106
P31
P4012
P496
0000-0001-6956-1736